Challenges and solutions to implementing drug-resistant tuberculosis programmes for children in Central Asia.
du Cros P, Swaminathan A, Bobokhojaev OI, Sharifovna ZD, Martin C, Herboczek K, Höhn C, Seddon JA
Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
Bastard M, Bonnet M, du Cros P, Khamraev AK, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F
Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis.
Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS
Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?
Bastard M, Bonnet M, du Cros P, Khamraev AK, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F
"I can also serve as an inspiration": a qualitative study of the TB&Me blogging experience and its role in MDR-TB treatment.
Horter S, Stringer B, Venis S, du Cros P
Towards the WHO target of zero childhood tuberculosis deaths: an analysis of mortality in 13 locations in Africa and Asia.
Russell GK, Merle CS, Cooke GS, Casas EC, Silveira da Fonseca M, du Cros P